Scholar Rock Holding SRRK
NASDAQ SRRK
$55.33 -0.61 (-1.09%)
As of: Sep 4, 2026 · 3:59 PM EDT

Scholar Rock Holding (SRRK) Times Interest Earned (2024 - 2026)

Scholar Rock Holding (SRRK) posted quarterly Times Interest Earned of -$43.08 for Q1 2026, down 14.62% year-over-year from -$50.46 in Q1 2025, and down 33.84% quarter-over-quarter from -$32.19 in Q4 2025.

Analysis

Scholar Rock Holding (SRRK) Times Interest Earned (2024 - 2026) Analysis & Trends

Scholar Rock Holding's Times Interest Earned history runs 10 years deep, the most recent figure standing at -$43.08 for Q1 2026.

  • In Q1 2026, Times Interest Earned fell 14.62% year-over-year to -$43.08; the TTM figure through Mar 2026 stood at -$46.08 (down 25.82% YoY), while the FY2025 annual figure was -$2.07, down 141.06% from the prior year.
  • Times Interest Earned for Q1 2026 stood at -$43.08, down from -$32.19 in the prior quarter.
  • The five-year high for Times Interest Earned was -$0.65 in Q3 2025, with the low at -$57.68 in Q2 2022.
  • The 5-year median for Times Interest Earned is -$21.83 (2024), against an average of -$23.39.
  • The sharpest annual moves came in 2022 and 2025: Times Interest Earned plunged 8814.95% in 2022, then surged 97.03% in 2025.
  • Scholar Rock Holding's Times Interest Earned stood at -$24.24 in 2022, then rose by 0.67% to -$24.08 in 2023, then slumped by 78.48% to -$42.97 in 2024, then increased by 25.1% to -$32.19 in 2025, then plunged by 33.84% to -$43.08 in 2026.
  • Business Quant data shows SRRK's Times Interest Earned at -$43.08 in Q1 2026, -$32.19 in Q4 2025, and -$0.65 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 117.59
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -493.00
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -21.24
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 8.18
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 2.82
8 Royalty Pharma 28.45 Bn 27.61 Bn - 1.42
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -0.08
10 Scholar Rock Holding 7.24 Bn 7.24 Bn - -24.10
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -24.10
Mar 31, 2026 -44.32
Dec 31, 2025 -36.27
Sep 30, 2025 -77.62
Jun 30, 2025 -92.96
Mar 31, 2025 -42.40
Dec 31, 2024 -42.14
Sep 30, 2024 -37.14
Jun 30, 2024 -34.69
Mar 31, 2024 -33.73